Cetera Investment Advisers Ionis Pharmaceuticals Inc Transaction History

Cetera Investment Advisers

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 24, 2024	BUY	$42.03 - $53.55 $914,488 - $1.17 Million	21,758 New	21,758 $943,000
Q1 2021 May 17, 2021	SELL	$42.51 - $63.78 $271,086 - $406,725	-6,377 Closed	0 $0
Q4 2020 Feb 17, 2021	BUY	$45.3 - $60.27 $97,485 - $129,701	2,152 Added 50.93%	6,377 $361,000
Q3 2020 Nov 13, 2020	SELL	$47.45 - $62.95 $10,439 - $13,849	-220 Reduced 4.95%	4,225 $200,000
Q2 2020 Aug 13, 2020	BUY	$46.85 - $61.05 $208,248 - $271,367	4,445 New	4,445 $262,000

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

Stay updated on Cetera Investment Advisers with notifications on news.